Tagged with Pharmaceutical

Pharma Beurs Van Berlage is an historic conference center in Amsterdam, hosting thousands of participants each year, many of them physicians, scientists, and professionals attending seminars, conferences, and meetings related to groundbreaking developments in medicine. The institution’s managing and commercial director discuss their organization’s suitability for hosting life science conferences. Could you…

Pharma Skanska Puerto Rico’s Ramon Navia discusses the challenges the sector has faced in recent years and how Skanska has adapted its services portfolio to better cater to local clients’ needs. Skanska provides world-class construction management services to the life science industry.  What differentiates Skanska from other competitors and makes the group the…

Pharma Colette Alma-Zeestraten tells PharmaBoardroom about how the Dutch Pharma Industry is adapting, how it is making use of clusters to become more competitive, energy efficient, and innovative, and how the nine billion euro contribution the pharmaceuticals sector makes to the Dutch chemicals industry. Over your last 10 years at the VNCI, what…

Turkey Over the past six years, Turkey has consistently lowered its drugs prices and guided its companies to greater efficiency. “Reference prices in Turkey are constructed from the lowest price in France, Greece, Italy, Spain or Portugal, converted to Turkish Lira at a rate of TRY 1.9595 per EUR,” says Cem…

Turkey In the coming years, Turkey plans to prioritize R&D initiatives, health studies and medical innovation: that’s the core message Minister of Health Mehmet Müezzinoğlu gave PharmaBoardroom. This is the beginning of a new era for healthcare in Turkey. The twenty-first century has already been a period of change in the…

Holland Pharming Group CEO Sijmen de Vries discusses the advantages of his company’s transgenic platform for recombinant protein production, the commercial progress of their lead product Ruconest, and the company’s plans for developing new applications through the platform, including a partnership with the SinoPharm subsidiary SIPI. From a production point of…

Holland A serial entrepreneur, Henk Viëtor founded the Drug Discovery Factory as an active venture fund focused on translating life science research into medical innovation. He discusses his perspective on the Dutch startup environment, and makes his case for how the country should proceed if it is serious about supporting the…

Holland Pivot Park in Oss, the Netherlands, aims at becoming an inspiring campus for open innovation in life sciences. The CEO discusses the unique assets the park offers to companies and calls for an increased collaboration among private industry, academia, and government to enhance the country’s global competitiveness. You took over…

Holland Floris de Gelder & Friso Smit share the story of Utrecht Science Park, the fastest growing science park in the Netherlands. The park’s companies do work in the fields of food and health, oncology, organoid technology, regenerative medicine, and personalized health. Mr de Gelder and Mr Smit share their vision for…

Holland Thijs De Kleer, Managing Director, Saco de Visser, Director Cluster Development, discuss recent developments at the Netherlands largest science park and how Leiden has positioned itself as a leader in early stages of development, which creates a great environment to foster innovation. Leiden lies at the center of the Dutch…

research AM Pharma is developing an innovative treatment for acute kidney injury, and minority investor Pfizer recently acquired the option to purchase the firms remaining equity upon the completion of a phase II clinical trial. How competitive do you feel Dutch life sciences in the academic setting are amongst your other…

healthcare Nefarma’s healthcare policy advisor discusses the changes in the Dutch reimbursement system over the previous five years, and the need for greater trust between different healthcare stakeholders to allow effective collaboration and negotiation. How has the pharmaceutical reimbursement system in the Netherlands changed over the last few years? To start…